Evidence map›Paper›PMID 36216963›Full record

ArticleScientific reports2022

Enterotypes in asthenospermia patients with obesity.

Jiao Jiao, Peng Xu, Xiaobin Wang, Ze Xing, Sitong Dong, Gaoyu Li, Xinrui Yao, Renhao Guo, Tao Feng, Weifan Yao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jiao Jiao *Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Peng Xu *SUSTC-SJH Joint Center for Human Reproduction and Genetics, Shenyang, China.
Xiaobin Wang *Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Ze XingCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Sitong DongCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Gaoyu LiCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Xinrui YaoCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Renhao GuoCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Tao FengGermountx Company, Beijing, China.
Weifan YaoSchool of Pharmacy, China Medical University, Shenyang, China.
Bochen PanCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China. panbochen@cmu.edu.cn.
Xuan ZhuSchool of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, China. zhuxuan@zjgsu.edu.cn.
Xiuxia WangCenter of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, China. wangxxsj@sina.cn.
China Medical University · CNHainan General Hospital · CNZhejiang Gongshang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The essence of enterotypes is stratifying the entire human gut microbiome, which modulates the association between diet and disease risk. A study was designed at the Center of Reproductive Medicine, Shengjing Hospital of China Medical University and Jinghua Hospital of Shenyang. Prevotella and Bacteroides were analyzed in 407 samples of stool, including 178 men with enterotype B (61 normal, 117 overweight/obese) and 229 men with enterotype P (74 normal, 155 overweight/obese). The ratio between Prevotella and Bacteroides abundance, P/B, was used as a simplified way to distinguish the predominant enterotype. In enterotype P group (P/B ≥ 0.01), obesity was a risk factor for a reduced rate of forward progressive sperm motility (odds ratio [OR] 3.350; 95% confidence interval [CI] 1.881-5.966; P < 0.001), and a reduced rate of total sperm motility (OR 4.298; 95% CI 2.365-7.809; P < 0.001). Obesity was also an independent risk factor (OR 3.131; 95% CI 1.749-5.607; P < 0.001) after adjusting follicle-stimulating hormone. In enterotype P, body mass index, as a diagnostic indicator of a reduced rate of forward progressive sperm motility and a decreased rate of decreased total sperm motility, had AUC values of 0.627 (P = 0.001) and 0.675 (P < 0.0001), respectively, which were significantly higher than the predicted values in all patients. However, in enterotype B group (P < 0.01), obesity was not a risk factor for asthenospermia, where no significant difference between obesity and sperm quality parameters was observed. This study is tried to introduce enterotypes as a population-based individualized classification index to investigate the correlation between BMI and asthenospermia. In our study, overweight/obese men with enterotype P were found to have poorer sperm quality. however, sperm quality was not associated with overweight/obese in men with enterotype B. Thereof, BMI is a risk factor for asthenospermia only in men with enterotype P, but not in men with enterotype B.

Indexed as

AsthenozoospermiaObesityOverweightBacteroidesBody Mass IndexFollicle Stimulating HormoneHumansMalePrevotellaSemenSperm MotilityFollicle Stimulating Hormone

Identifiers

PMID36216963
PMCPMC9550853
OpenAlexW4304013999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.